Improvement of zoledronic-acid-induced jaw osteonecrosis with bortezomib

MeSH terms

• Anti-Inflammatory Agents, Non-Steroidal / pharmacology
• Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
• Antineoplastic Agents / pharmacology
• Antineoplastic Agents / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Boronic Acids / pharmacology
• Boronic Acids / therapeutic use*
• Bortezomib
• Dexamethasone
• Diphosphonates / adverse effects*
• Doxorubicin
• Female
• Humans
• Imidazoles / adverse effects*
• Mandibular Diseases / chemically induced
• Mandibular Diseases / drug therapy*
• Middle Aged
• Multiple Myeloma / drug therapy*
• Multiple Myeloma / surgery
• Osteonecrosis / chemically induced
• Osteonecrosis / drug therapy*
• Peripheral Blood Stem Cell Transplantation
• Postoperative Complications / chemically induced
• Postoperative Complications / drug therapy*
• Protease Inhibitors / pharmacology
• Protease Inhibitors / therapeutic use*
• Pyrazines / pharmacology
• Pyrazines / therapeutic use*
• Tooth Extraction / adverse effects
• Transplantation, Autologous
• Vincristine
• Zoledronic Acid